Figure 1.
Global HPV vaccination status, cervical cancer burden, and regional HPV prevalence. This figure illustrates the global HPV vaccination status, showing that 27% of girls received the first dose of the HPV vaccine, far short of the WHO’s target of 90% coverage by 2030. It quantifies the annual impact of 690,000 new HPV-related cancer cases. The figure also highlights that cervical cancer, mostly caused by chronic HPV infection, is the fourth most frequent cancer among women worldwide. The prevalence of cervical HPV is highest in sub-Saharan Africa (24%), followed by Latin America and the Caribbean (16%), Eastern Europe (14%), and South-East Asia (14%).
